GlaxoSmithKline: Prostatic Neoplasms trials
The registry lists 17 Prostatic Neoplasms studies with GlaxoSmithKline as lead sponsor. 3 are open to participants now and 4 have results posted.
Phase 1 6Phase 2 3Phase 3 3Phase 4 3No phase 4(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- A Study of Risvutatug Rezetecan in Participants With Metastatic Castration-resistant Prostate Cancer (mCRPC) [EMBOLD Prostate-302]RecruitingNCT07802704Phase 3
- First-Time-in-Human Study of GSK5471713 in Adults With mCRPCRecruitingNCT07332455Phase 1/2
- A Study of GSK5458514 Administered Alone or In Combination With Other Anti-Cancer Agents in Participants With Prostate CancerRecruitingNCT06990880Phase 1/2
- ARTS - AVODART After Radical Therapy For Prostate Cancer StudyCompletedNCT00558363Phase 2Results posted
- Prostate Cancer Study In Men Who Have Failed First-Line Androgen Deprivation TherapyCompletedNCT00470834Phase 4Results posted
- Assessment Of Dutasteride (AVODART) In Extending The Time To Progression Of Low-Risk, Localized Prostate Cancer In MenCompletedNCT00363311Phase 4Results posted
- "REDUCE" - A Clinical Research Study To Reduce The Incidence Of Prostate Cancer In Men Who Are At Increased RiskCompletedNCT00056407Phase 3Results posted
- Patient-Reported Outcome Measurement Information System (PROMIS) Physical FunctionCompletedNCT03351140
- A Study of HGS1036 in Combination With Chemotherapy in Subjects With Advanced Solid MalignanciesSuspendedNCT01604863Phase 1
- Korean Practice Patterns for Screening PCA(Prostate Cancer)CompletedNCT01371513
- Economic Analyses of the REDUCE TrialCompletedNCT01337258
- A Study of PNT2258 in Patients With Advanced Solid TumorsCompletedNCT01191775Phase 1
- ARI103094-Follow-Up Study for REDUCE Study SubjectsCompletedNCT00883909
- A Study of MK4827 in Participants With Advanced Solid Tumors or Hematologic Malignancies (MK-4827-001 AM8)CompletedNCT00749502Phase 1
- Effects On Dihydrotestosterone Regulated Gene Expression In Benign Prostatic Hyperplasia Or Prostate CancerCompletedNCT00375765Phase 4
- Effects Of Nadroparin In Patients With Lung, Pancreas Or Prostate CancerCompletedNCT00312013Phase 3
- Safety & Activity of P501-AS15 Vaccine as a First-line Treatment for Patients With Hormone-sensitive Prostate Cancer Who Show Rising PSACompletedNCT00148928Phase 1